Pfizer Reports First-Quarter 2008 Results
- Details
- Category: Pfizer

Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter
- Details
- Category: Abbott

- Diluted earnings per share, excluding specified items, were $0.63, reflecting 14.5 percent growth, at the upper end of Abbott's previously announced guidance range of $0.61 to $0.63. Diluted earnings per share under Generally Accepted Accounting Principles (GAAP) were $0.60, up 33.3 percent.
Roche fully acquires privately-owned biotech company Piramed
- Details
- Category: Roche

Patients with early Parkinson's disease show better symptom control
- Details
- Category: Novartis

AstraZeneca Settles US Nexium Patent Litigation with Ranbaxy
- Details
- Category: AstraZeneca

Dr. Reddy's acquires Jet Generici Srl. Acquisition to establish Generics business in Italy
- Details
- Category: Business

Novartis to first acquire 25% stake from Nestlé for USD 143.18 per share for USD 11 billion
- Details
- Category: Novartis

More Pharma News ...
- The first vaccine licensed to complete the rotavirus immunisation series by four months of age
- International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM)
- Lipitor Provided an Unexpectedly Potent Heart Benefit
- Pfizer Successfully Completes Tender Offer for Shares of Encysive Pharmaceuticals Inc.
- Rasilez® reduces left ventricular hypertrophy, a powerful predictor of heart disease
- Bayer appeals invalidity ruling on its Yasmin® Patent
- Crestor Outcomes Study JUPITER Closes Early Due To Unequivocal Evidence Of Benefit